[Methenamine hippurate VUFB and mandelamine VUFB in the prevention of recurrent dysuria in women].
D000328:Adult; D000368:Aged; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use*; D001419:Bacteria / Q000302:isolation & purification; D001437:Bacteriuria / Q000517:prevention & control*; D005260:Female; D006626:Hippurates / Q000627:therapeutic use*; D006801:Humans; D008333:Mandelic Acids / Q000627:therapeutic use*; D008709:Methenamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D010146:Pain; D012008:Recurrence; D014555:Urination Disorders / Q000382:microbiology / Q000517:prevention & control*
D000892:Anti-Infective Agents, Urinary; D006626:Hippurates; D008333:Mandelic Acids; C023055:methenamine mandelate; D008709:Methenamine; C011481:methenamine hippurate
Methenamin hippurat VUFB a Mandelamin VUFB pri profylaxi recidivujících dyzurií u zen.